APA (7th ed.) Citation

Cortese, S., Coghill, D., Fegert, J. M., Mattingly, G. W., Rohde, L. A., Wong, I. C., & Faraone, S. V. (2024). ESCAP endorses the inclusion of methylphenidate in the WHO model lists of essential medicines and in the Union list of critical medicines. European Child & Adolescent Psychiatry, 33(5), 1605. https://doi.org/10.1007/s00787-024-02443-5

Chicago Style (17th ed.) Citation

Cortese, Samuele, David Coghill, Joerg M. Fegert, Gregory W. Mattingly, Luis A. Rohde, Ian C.K Wong, and Stephen V. Faraone. "ESCAP Endorses the Inclusion of Methylphenidate in the WHO Model Lists of Essential Medicines and in the Union List of Critical Medicines." European Child & Adolescent Psychiatry 33, no. 5 (2024): 1605. https://doi.org/10.1007/s00787-024-02443-5.

MLA (9th ed.) Citation

Cortese, Samuele, et al. "ESCAP Endorses the Inclusion of Methylphenidate in the WHO Model Lists of Essential Medicines and in the Union List of Critical Medicines." European Child & Adolescent Psychiatry, vol. 33, no. 5, 2024, p. 1605, https://doi.org/10.1007/s00787-024-02443-5.